Novo Nordisk Prices High-Dose Wegovy Lower Than Eli Lilly's Zepbound

Novo Nordisk has launched the high-dose version of its GLP-1 injection, Wegovy, at a price point $50 lower than Eli Lilly's competing drug, Zepbound. This strategic pricing aims to position Wegovy competitively in the market.

8 Apr, 10:15 — 8 Apr, 10:15

Post Share

Sources

Showing 1 of 1 sources

marketwatchMostly Factual10h ago

A high dose of Wegovy will cost $50 less than Zepbound

Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 lower than the one for Eli Lilly’s competing drug.

By Jaimy Lee

Read full article →

PERSPECTA

PERSPECTA

Novo Nordisk Prices High-Dose Wegovy Lower Than Eli Lilly's Zepbound

Sources

A high dose of Wegovy will cost $50 less than Zepbound

Related Stories

Brian Poe calls for ‘people’s hearing’ on oil crisis, energy reforms

Manila Water Prepares for Summer Heat and High Demand

CHEd allows HEIs to shift to online classes amid oil crisis

Philippine Lottery Draws Yield No Jackpot Winners on April 8

PERSPECTA